Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

The Tennessee medication therapy management program: A hybrid type 2 effectiveness-implementation trial study protocol.

Woeppel J, Clark R, Underwood L, Gatwood J, Turner K, Renfro C, Hohmeier KC.

Res Social Adm Pharm. 2019 May 24. pii: S1551-7411(19)30551-0. doi: 10.1016/j.sapharm.2019.05.018. [Epub ahead of print]

PMID:
31151919
2.

Economic viability of tech-check-tech in an independent community pharmacy.

Gatwood J, Martin H, Newsome R, Hohmeier KC.

J Am Pharm Assoc (2003). 2019 Jul - Aug;59(4):570-574. doi: 10.1016/j.japh.2019.02.013. Epub 2019 Apr 9.

PMID:
30979577
3.

Exploring the implementation of a novel optimizing care model in the community pharmacy setting.

Hohmeier KC, Desselle SP.

J Am Pharm Assoc (2003). 2019 May - Jun;59(3):310-318. doi: 10.1016/j.japh.2019.02.006. Epub 2019 Mar 30.

PMID:
30940516
4.

Assessing pharmacy technician certification: A national survey comparing certified and noncertified pharmacy technicians.

Wheeler JS, Renfro CP, Wang J, Qiao Y, Hohmeier KC.

J Am Pharm Assoc (2003). 2019 May - Jun;59(3):369-374.e2. doi: 10.1016/j.japh.2018.12.021. Epub 2019 Feb 8.

PMID:
30745189
5.

Consultant Pharmacist⁻Provider Collaboration in U.S. Assisted Living Facilities: A Pilot Study.

Hohmeier KC, Frederick KD, Patel K, Summers K, Honeycutt M.

Pharmacy (Basel). 2019 Feb 1;7(1). pii: E17. doi: 10.3390/pharmacy7010017.

6.

Exploring the expanded role of the pharmacy technician in medication therapy management service implementation in the community pharmacy.

Hohmeier KC, McDonough SLK, Rein LJ, Brookhart AL, Gibson ML, Powers MF.

J Am Pharm Assoc (2003). 2019 Mar - Apr;59(2):187-194. doi: 10.1016/j.japh.2018.11.006. Epub 2019 Jan 21.

PMID:
30679031
7.

Beyond the reminder: The next steps in pharmacist-driven, mHealth patient engagement.

Gatwood J, Hohmeier KC, Brooks IM.

J Am Pharm Assoc (2003). 2019 Mar - Apr;59(2S):S21-S24. doi: 10.1016/j.japh.2018.10.003. Epub 2018 Nov 15.

PMID:
30448025
8.

Student Perceptions of the Pharmacist's Approach Across the Varying Levels of Medication Therapy Management Services.

Hohmeier KC, Spivey C, Collier C, Chisholm-Burns M.

Am J Pharm Educ. 2018 Feb;82(1):6190. doi: 10.5688/ajpe6190.

9.

A community-based partnership collaborative practice agreement project to teach innovation in care delivery.

Hohmeier KC, Spivey CA, Chisholm-Burns M.

Curr Pharm Teach Learn. 2017 May;9(3):473-478. doi: 10.1016/j.cptl.2017.02.004. Epub 2017 Apr 14.

PMID:
29233287
10.

Implementation of a health information exchange into community pharmacy workflow.

Hohmeier KC, Spivey CA, Boldin S, Moore TB, Chisholm-Burns M.

J Am Pharm Assoc (2003). 2017 Sep - Oct;57(5):608-615. doi: 10.1016/j.japh.2017.05.009. Epub 2017 Jul 18.

PMID:
28733155
11.

Consumer perceptions of and willingness-to-pay for point-of-care testing services in the community pharmacy.

Hohmeier KC, Loomis B, Gatwood J.

Res Social Adm Pharm. 2018 Apr;14(4):360-366. doi: 10.1016/j.sapharm.2017.04.011. Epub 2017 Apr 26.

PMID:
28457907
12.

A multimodal approach to improving human papillomavirus vaccination in a community pharmacy setting.

Hohmeier KC, Randolph DD, Smith CT, Hagemann TM.

SAGE Open Med. 2016 Dec 14;4:2050312116682128. doi: 10.1177/2050312116682128. eCollection 2016.

13.

Availability of drug information on community pharmacy websites in Tennessee.

Borja-Hart N, Hohmeier KC.

Int J Pharm Pract. 2017 Jun;25(3):244-247. doi: 10.1111/ijpp.12350. Epub 2017 Feb 9.

PMID:
28181321
14.

Pharmacogenomics testing in a community pharmacy: patient perceptions and willingness-to-pay.

Gibson ML, Hohmeier KC, Smith CT.

Pharmacogenomics. 2017 Feb;18(3):227-233. doi: 10.2217/pgs-2016-0161. Epub 2017 Jan 23.

PMID:
28112585
15.

Evaluating the Impact of Pharmacists on Reducing Use of Sedative/Hypnotics for Treatment of Insomnia in Long-Term Care Facility Residents.

Gemelli MG, Yockel K, Hohmeier KC.

Consult Pharm. 2016 Nov 1;31(11):650-657. doi: 10.4140/TCP.n.2016.650.

PMID:
28107122
16.

Impact of Medicare Part D on Racial and Ethnic Minorities.

Jamison JJ, Wang J, Surbhi S, Adams S, Solomon D, Hohmeier KC, McDonough S, Eoff JC 3rd.

Divers Equal Health Care. 2016;13(5):326-333. Epub 2016 Aug 23.

17.

Behavioral, mental, and physical health characteristics and opioid medication misuse among community pharmacy patients: A latent class analysis.

Cochran G, Hruschak V, Bacci JL, Hohmeier KC, Tarter R.

Res Social Adm Pharm. 2017 Nov;13(6):1055-1061. doi: 10.1016/j.sapharm.2016.11.005. Epub 2016 Nov 15.

18.

Training and retaining community pharmacy leaders: Career pathways after completing a PGY1 community pharmacy residency affiliated with a large supermarket chain.

Hohmeier KC, Borja-Hart N, Cooper M, Kirby J, Fisher C.

J Am Pharm Assoc (2003). 2017 Jan - Feb;57(1):82-85. doi: 10.1016/j.japh.2016.08.013. Epub 2016 Nov 8.

PMID:
27836480
19.

Co-creation of market expansion in point-of-care testing in the United States: Industry leadership perspectives on the community pharmacy segment.

Hohmeier KC, McDonough SLK, Wang J.

Res Social Adm Pharm. 2017 Jul - Aug;13(4):746-753. doi: 10.1016/j.sapharm.2016.09.008. Epub 2016 Oct 27.

PMID:
27818213
20.

Are patient's simply unaware? A cross-sectional study of website promotion of community pharmacy adherence-related services in Tennessee.

Hohmeier KC, Borja-Hart N.

Res Social Adm Pharm. 2016 Nov - Dec;12(6):1004-1009. doi: 10.1016/j.sapharm.2015.11.004. Epub 2015 Nov 19.

PMID:
26706404

Supplemental Content

Loading ...
Support Center